During the last three months, 4 analysts shared their evaluations of Maravai LifeSciences (NASDAQ:MRVI), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Maravai LifeSciences, presenting an average target of $9.0, a high estimate of $11.00, and a low estimate of $7.00. Surpassing the previous average price target of $8.62, the current average has increased by 4.41%.
Interpreting Analyst Ratings: A Closer Look
The standing of Maravai LifeSciences among financial...
Login or create a forever free account to read this news
Sign up/Log in